Medico Remedies Ltd. (IN:MEDICO)

:MEDICO

MEDICO

Medico Remedies Ltd.

RESEARCH TOOLSreports

Want to see IN:MEDICO full AI Analyst Report?

Medico Remedies Ltd. (MEDICO) Price & Analysis

0 Followers

MEDICO Stock Chart & Stats

₹50.16

₹4.58(8.10%)

At close: Jan 08 4:00 PM EST

₹50.16

₹4.58(8.10%)

Day’s Range― - ―

52-Week Range₹31.00 - ₹59.00

Previous CloseN/A

Volume2.72M

Average Volume (3M)12.74K

Market Cap

₹3.79B

Enterprise Value₹3.94B

Total Cash (Recent Filing)₹17.64M

Total Debt (Recent Filing)₹125.27M

Price to Earnings (P/E)36.5

Beta0.17

Next Earnings

May 21, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)1.37

Shares Outstanding82,984,000

10 Day Avg. Volume20,955

30 Day Avg. Volume12,740

Financial Highlights & Ratios

PEG Ratio1.99

Price to Book (P/B)7.06

Price to Sales (P/S)2.92

P/FCF Ratio258.26

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth & Improving ProfitabilityConsistent top-line expansion and improving net margins indicate durable demand and better pricing or mix. Over the next 2–6 months this supports reinvestment capacity, strengthens operating leverage, and provides a foundation for continuing margin improvement if cost trends remain controlled.

Prudent Leverage And Solid Equity BaseA solid equity base and favorable debt-to-equity profile provide financial flexibility and lower solvency risk. Improving ROE shows effective capital use, enabling the company to fund growth internally and withstand sector headwinds without over-reliance on external financing.

Strong Cash ConversionRobust operating cash conversion demonstrates the business can translate earnings into cash, supporting capex, working capital, and strategic initiatives. Sustained cash generation enhances balance sheet resilience and funds reinvestment without immediate need for external capital.

Bears Say

Capital Expenditure Pressure On Free Cash FlowElevated capex that materially reduces free cash flow limits discretionary liquidity for dividends, buybacks or M&A. If capex remains high, it can strain near-term flexibility and force trade-offs between growth investments and shareholder returns over the coming months.

Volatile Operating Efficiency (EBIT Margin)Unstable EBIT margins indicate variable cost control or fluctuating product mix, which makes earnings less predictable. This operational volatility can hinder planning, increase sensitivity to input cost swings, and pressure margins if not addressed by management.

Moderate Reliance On LiabilitiesA moderate dependence on liabilities raises refinancing and interest-rate exposure, particularly if market conditions tighten. This reliance can constrain strategic moves and elevate risk during downturns unless management keeps leverage under control and maintains cash buffers.

Medico Remedies Ltd. News

Medico Remedies Announces 31st AGM Details

Medico Remedies Ltd. ( ($IN:MEDICO) ) has provided an update. Medico Remedies Limited has announced the completion of...

10M ago

MEDICO FAQ

What was Medico Remedies Ltd.’s price range in the past 12 months?

Medico Remedies Ltd. lowest stock price was ₹31.00 and its highest was ₹59.00 in the past 12 months.

What is Medico Remedies Ltd.’s market cap?

Medico Remedies Ltd.’s market cap is ₹3.79B.

When is Medico Remedies Ltd.’s upcoming earnings report date?

Medico Remedies Ltd.’s upcoming earnings report date is May 21, 2026 which is today.

How were Medico Remedies Ltd.’s earnings last quarter?

Currently, no data Available

Is Medico Remedies Ltd. overvalued?

According to Wall Street analysts Medico Remedies Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Medico Remedies Ltd. pay dividends?

Medico Remedies Ltd. does not currently pay dividends.

What is Medico Remedies Ltd.’s EPS estimate?

Medico Remedies Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Medico Remedies Ltd. have?

Medico Remedies Ltd. has 82,984,000 shares outstanding.

What happened to Medico Remedies Ltd.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Medico Remedies Ltd.?

Currently, no hedge funds are holding shares in IN:MEDICO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Medico Remedies Ltd.

Medico Remedies Limited manufactures and sells allopathic pharmaceutical preparations in India. The company offers antibiotics and anti-infective drugs; beta-lactams, and penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, and anti-epileptics and antipsychotics products; antimalarial medicines; dry syrups; ointments and creams; anti-diabetics products; and syrups. It also exports its products to Kazakhstan, Kyrgyzstan, Botswana, Jamaica, and Niger. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.